カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の非侵襲式薬物送達市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Non-Invasive Drug Delivery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8217）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8217
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の非侵襲式薬物送達市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

非侵襲式薬物送達市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の非侵襲式薬物送達の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

非侵襲式薬物送達市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・人工膵臓、無針注射器、デジタル呼吸装置、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界の非侵襲式薬物送達市場の主要な市場プレーヤーは以下のとおりです。
・Adherium Limited、Capsule Technologies, Inc.、Crossject S.A.、Diabeloop SA、HNS International, Inc.、Inovio Pharmaceuticals, Inc.、Medtronic Plc.、Novartis AG、PenJet Corporation、PharmaJet、Portal Instruments、ResMed、Sensiron AG、Tandem Diabetes Care, Inc.、Teva Pharmaceuticals Industries Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、非侵襲式薬物送達製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非侵襲式薬物送達メーカーの企業概要、2019年～2022年までの非侵襲式薬物送達の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非侵襲式薬物送達メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別非侵襲式薬物送達の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの非侵襲式薬物送達の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での非侵襲式薬物送達市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および非侵襲式薬物送達の産業チェーンを掲載しています。
・第13、14、15章では、非侵襲式薬物送達の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Adherium Limited、Capsule Technologies, Inc.、Crossject S.A.、Diabeloop SA、HNS International, Inc.、Inovio Pharmaceuticals, Inc.、Medtronic Plc.、Novartis AG、PenJet Corporation、PharmaJet、Portal Instruments、ResMed、Sensiron AG、Tandem Diabetes Care, Inc.、Teva Pharmaceuticals Industries Ltd.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：人工膵臓、無針注射器、デジタル呼吸装置、その他
・用途別分析2017年-2028年：病院、クリニック、その他
・非侵襲式薬物送達の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・非侵襲式薬物送達のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・非侵襲式薬物送達のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・非侵襲式薬物送達の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・非侵襲式薬物送達の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Non-Invasive Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-Invasive Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-Invasive Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Artificial Pancreas segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-Invasive Drug Delivery include Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, and HNS International, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-Invasive Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Non-Invasive Drug Delivery market are listed below:
Adherium Limited
Capsule Technologies, Inc.
Crossject S.A.
Diabeloop SA
HNS International, Inc.
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Novartis AG
PenJet Corporation
PharmaJet
Portal Instruments
ResMed
Sensiron AG
Tandem Diabetes Care, Inc.
Teva Pharmaceuticals Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Invasive Drug Delivery, with price, sales, revenue and global market share of Non-Invasive Drug Delivery from 2019 to 2022.
Chapter 3, the Non-Invasive Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-Invasive Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Drug Delivery.
Chapter 13, 14, and 15, to describe Non-Invasive Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Non-Invasive Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-Invasive Drug Delivery Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-Invasive Drug Delivery Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-Invasive Drug Delivery Market Size & Forecast
1.4.1 Global Non-Invasive Drug Delivery Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-Invasive Drug Delivery Sales in Volume (2017-2028)
1.4.3 Global Non-Invasive Drug Delivery Price (2017-2028)
1.5 Global Non-Invasive Drug Delivery Production Capacity Analysis
1.5.1 Global Non-Invasive Drug Delivery Total Production Capacity (2017-2028)
1.5.2 Global Non-Invasive Drug Delivery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Drug Delivery Market Drivers
1.6.2 Non-Invasive Drug Delivery Market Restraints
1.6.3 Non-Invasive Drug Delivery Trends Analysis
2 Manufacturers Profiles
2.1 Adherium Limited
2.1.1 Adherium Limited Details
2.1.2 Adherium Limited Major Business
2.1.3 Adherium Limited Non-Invasive Drug Delivery Product and Services
2.1.4 Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Capsule Technologies, Inc.
2.2.1 Capsule Technologies, Inc. Details
2.2.2 Capsule Technologies, Inc. Major Business
2.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product and Services
2.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Crossject S.A.
2.3.1 Crossject S.A. Details
2.3.2 Crossject S.A. Major Business
2.3.3 Crossject S.A. Non-Invasive Drug Delivery Product and Services
2.3.4 Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Diabeloop SA
2.4.1 Diabeloop SA Details
2.4.2 Diabeloop SA Major Business
2.4.3 Diabeloop SA Non-Invasive Drug Delivery Product and Services
2.4.4 Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 HNS International, Inc.
2.5.1 HNS International, Inc. Details
2.5.2 HNS International, Inc. Major Business
2.5.3 HNS International, Inc. Non-Invasive Drug Delivery Product and Services
2.5.4 HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Inovio Pharmaceuticals, Inc.
2.6.1 Inovio Pharmaceuticals, Inc. Details
2.6.2 Inovio Pharmaceuticals, Inc. Major Business
2.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product and Services
2.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medtronic Plc.
2.7.1 Medtronic Plc. Details
2.7.2 Medtronic Plc. Major Business
2.7.3 Medtronic Plc. Non-Invasive Drug Delivery Product and Services
2.7.4 Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Non-Invasive Drug Delivery Product and Services
2.8.4 Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 PenJet Corporation
2.9.1 PenJet Corporation Details
2.9.2 PenJet Corporation Major Business
2.9.3 PenJet Corporation Non-Invasive Drug Delivery Product and Services
2.9.4 PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 PharmaJet
2.10.1 PharmaJet Details
2.10.2 PharmaJet Major Business
2.10.3 PharmaJet Non-Invasive Drug Delivery Product and Services
2.10.4 PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Portal Instruments
2.11.1 Portal Instruments Details
2.11.2 Portal Instruments Major Business
2.11.3 Portal Instruments Non-Invasive Drug Delivery Product and Services
2.11.4 Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ResMed
2.12.1 ResMed Details
2.12.2 ResMed Major Business
2.12.3 ResMed Non-Invasive Drug Delivery Product and Services
2.12.4 ResMed Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sensiron AG
2.13.1 Sensiron AG Details
2.13.2 Sensiron AG Major Business
2.13.3 Sensiron AG Non-Invasive Drug Delivery Product and Services
2.13.4 Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Tandem Diabetes Care, Inc.
2.14.1 Tandem Diabetes Care, Inc. Details
2.14.2 Tandem Diabetes Care, Inc. Major Business
2.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product and Services
2.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Teva Pharmaceuticals Industries Ltd.
2.15.1 Teva Pharmaceuticals Industries Ltd. Details
2.15.2 Teva Pharmaceuticals Industries Ltd. Major Business
2.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product and Services
2.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-Invasive Drug Delivery Breakdown Data by Manufacturer
3.1 Global Non-Invasive Drug Delivery Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-Invasive Drug Delivery Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-Invasive Drug Delivery
3.4 Market Concentration Rate
3.4.1 Top 3 Non-Invasive Drug Delivery Manufacturer Market Share in 2021
3.4.2 Top 6 Non-Invasive Drug Delivery Manufacturer Market Share in 2021
3.5 Global Non-Invasive Drug Delivery Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-Invasive Drug Delivery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-Invasive Drug Delivery Market Size by Region
4.1.1 Global Non-Invasive Drug Delivery Sales in Volume by Region (2017-2028)
4.1.2 Global Non-Invasive Drug Delivery Revenue by Region (2017-2028)
4.2 North America Non-Invasive Drug Delivery Revenue (2017-2028)
4.3 Europe Non-Invasive Drug Delivery Revenue (2017-2028)
4.4 Asia-Pacific Non-Invasive Drug Delivery Revenue (2017-2028)
4.5 South America Non-Invasive Drug Delivery Revenue (2017-2028)
4.6 Middle East and Africa Non-Invasive Drug Delivery Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-Invasive Drug Delivery Sales in Volume by Type (2017-2028)
5.2 Global Non-Invasive Drug Delivery Revenue by Type (2017-2028)
5.3 Global Non-Invasive Drug Delivery Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-Invasive Drug Delivery Sales in Volume by Application (2017-2028)
6.2 Global Non-Invasive Drug Delivery Revenue by Application (2017-2028)
6.3 Global Non-Invasive Drug Delivery Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-Invasive Drug Delivery Sales by Type (2017-2028)
7.2 North America Non-Invasive Drug Delivery Sales by Application (2017-2028)
7.3 North America Non-Invasive Drug Delivery Market Size by Country
7.3.1 North America Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
7.3.2 North America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-Invasive Drug Delivery Sales by Type (2017-2028)
8.2 Europe Non-Invasive Drug Delivery Sales by Application (2017-2028)
8.3 Europe Non-Invasive Drug Delivery Market Size by Country
8.3.1 Europe Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-Invasive Drug Delivery Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-Invasive Drug Delivery Sales by Type (2017-2028)
9.2 Asia-Pacific Non-Invasive Drug Delivery Sales by Application (2017-2028)
9.3 Asia-Pacific Non-Invasive Drug Delivery Market Size by Region
9.3.1 Asia-Pacific Non-Invasive Drug Delivery Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-Invasive Drug Delivery Sales by Type (2017-2028)
10.2 South America Non-Invasive Drug Delivery Sales by Application (2017-2028)
10.3 South America Non-Invasive Drug Delivery Market Size by Country
10.3.1 South America Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
10.3.2 South America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-Invasive Drug Delivery Sales by Type (2017-2028)
11.2 Middle East & Africa Non-Invasive Drug Delivery Sales by Application (2017-2028)
11.3 Middle East & Africa Non-Invasive Drug Delivery Market Size by Country
11.3.1 Middle East & Africa Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-Invasive Drug Delivery Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-Invasive Drug Delivery and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-Invasive Drug Delivery
12.3 Non-Invasive Drug Delivery Production Process
12.4 Non-Invasive Drug Delivery Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-Invasive Drug Delivery Typical Distributors
13.3 Non-Invasive Drug Delivery Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射可能ドラッグデリバリー機器市場2022年：市場規模予測（～2028年）
  • 世界の注射可能ドラッグデリバリーデバイス市場2022年：市場規模予測（～2028年）
  • 世界の輸液ドラッグデリバリーデバイス市場2022年：市場規模予測（～2028年）
  • 世界の眼科用薬物送達システム市場2022年：市場規模予測（～2028年）
  • 世界の非侵襲皮膚閉鎖デバイス市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8217 )"世界の非侵襲式薬物送達市場2022年：市場規模予測（～2028年）" (英文：Global Non-Invasive Drug Delivery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。